IDEXX Laboratories Inc. (Nasdaq: IDXX) has developed a diagnostic test to help veterinarians detect kidney injury in cats and dogs at an earlier stage to improve treatment. The Westbrook-based ...

WESTBROOK, Maine, Jan. 12, 2024 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announced the expansion of its Fecal Dx® antigen testing platform ...

IDEXX Laboratories, Inc. IDXX recently expanded its Fecal Dx antigen testing platform with the addition of Cystoisospora — a common intestinal parasite that is the source of diarrhea, weight loss and ...

In recent years, much of the attention Idexx Laboratories has received has been related to its "companion animal" business, which develops diagnostics, drugs and software systems for veterinarians who ...

IDEXX Laboratories is a leader in animal diagnostics, boasting strong recurring revenue and nearly 50% stock gains year-to-date. IDXX's innovation pipeline, robust cash position, and global reach ...

Pet healthcare is a large and growing global market. Veterinarians are rapidly adopting in-office diagnostic testing tools. Increased testing is the foundation of Idexx's attractive recurring-revenue ...

Macquarie Asset Management, an investment management company, released its “Macquarie Large Cap Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. In the ...